Caribou Biosciences
Stephen is the Robert and Margarita Louis-Dreyfus Professor of Chronic Lymphocytic Leukemia and Lymphoma and the director of the Lymphoma Program and Lymphoma Translational Research at the Perelman School of Medicine at the University of Pennsylvania, with Penn Medicine’s Abramson Cancer Center. With a medical career spanning over 40 years, he is a world-renowned hematologist-oncologist with expertise in lymphoma and related diseases. His clinical and translational research has resulted in over 200 peer reviewed articles and participation in numerous clinical trials. After graduating AOA from Jefferson Medical College and completing his residency at Pennsylvania Hospital, Stephen completed clinical and research fellowships at the Cardeza Foundation for Hematologic Research. In 1989, he became a member of the Cardeza Foundation at Jefferson Medical College. Stephen joined the University of Pennsylvania in 1998.
This person is not in the org chart
This person is not in any offices
Caribou Biosciences
2 followers
Caribou Biosciences is a leading clinical-stage CRISPR genome editing biotechnology company founded by pioneers of CRISPR biology and located in Berkeley, CA. The company is developing an internal pipeline of off-the-shelf, genome-edited CAR-T and natural killer (NK) cell therapies.